Innovative Leukemia and Lymphoma Therapy (Basic and Clinical Oncology)

Written by international experts in the field, this new guideexamines cutting-edge clinical studies that investigate innovative therapies and related topics for leukemia and lymphoma including:
· tyrosine kinase inhibitors, histon deacetylase inhibitors, and farnesyl transferase inhibitors
· radioimmunotherapy, gene-directed therapy, and immunotherapy by vaccination
· monoclonal antibodies
· anti-angiogenesis approaches
· the concerns of conventional but novel anticancer agents
· modulation of classical multidrug resistance
· modulators of single agent drug resistance.
Innovative Leukemia and Lymphoma Therapy is the only comprehensive and up-to-date overview of the exciting new treatment modalities in leukemia and lymphoma in practice today